Trump and RFK Double Down on Controversial Tylenol Claims at ‘Fat Drug’ Presser: ‘The Science Hasn’t Changed!

President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. doubled down on their controversial claims about Tylenol during an Oval Office press conference Thursday. Kennedy was commenting on the Trump administration’s announcement that Americans would be getting affordable pricing on GLP-1 weight loss drugs like Ozempic and Wegovy when Trump brought […]

Trump Announces Deal To Reduce Weight Loss Drug Prices

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years. Read the best […]

Trump Strikes Deal to Offer Americans GLP-1 Drugs for Much Cheaper

With Donald Trump reaping his lowest approval rating of all-time, it’s only natural he’d scramble to throw voters a bone. Apparently, that came in the form of a huge government-mediated discount on the blockbuster weight loss drugs known as GLP-1s, like Wegovy and Zepbound. As reported by the Washington Post prior to the event, Trump […]

Trump strikes major deal with pharma giants Lilly and Novo over obesity drugs, Medicare

Health and Human Services Secretary Robert F. Kennedy Jr. is working on identifying and tackling the root causes of America’s obesity epidemic. In the meantime, the Trump administration wants to make sure that Americans have access to affordable diabetes and weight-loss drugs, specifically glucagon-like peptide-1 receptor agonists, better known as GLP-1 drugs. To this end […]

Trump announces deal with Eli Lilly, Novo Nordisk to lower prices on obesity drugs

The Trump administration announced its newest pharmaceutical agreement under its Most Favored Nation policy Thursday, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 products at discounted prices.  According to senior administration officials, the two manufacturers have agreed to sell their injectable GLP-1 products for a monthly starting price starting of $245 for people on Medicare and Medicaid, as well as…

Trump announces deal with drugmakers to lower cost of weight-loss drugs

President Donald Trump on Thursday announced deals with pharmaceutical giants Novo Nordisk and Eli Lilly that would cut the cost of the lowest doses of their in-demand weight-loss drugs, lowering the barrier for new patients to access treatment. Under the plan, Novo Nordisk said the lowest doses of Wegovy will cost $149 for a month’s […]